When DNA becomes the hard drive of tomorrow, BIOMEMORY raises 17 million euros from CREDIT MUTUEL INNOVATION

With our partner Salesforce, unify sales, marketing and customer service. Accelerate your growth!

Faced with the explosion of data storage needs, traditional infrastructures are struggling to keep pace. 60% of data generated today is stored on magnetic tape, a market estimated to be worth $6.5 billion in 2023, and expected to exceed $40 billion by 2030.

Offering a less expensive alternative, with a stronger ecological impact than current solutions are among the objectives of the French startup Biomemory who decided to work on a solution for storing digital data on DNA.

The idea of ​​storing data on DNA was introduced by Richard P. Feynman in 1959, and has been explored by various universities and companies. Recent technological advances, combined with environmental issues, make this avenue more and more relevant. Many researchers, including at MIT and the University of North Carolina, have developed systems to identify and protect DNA strands used for storage.

It is in this context that DNA emerges as a relevant alternative. Capable of storing 215 petabytes of data (215 million gigabytes) per gram, DNA is infinitely denser than current technologies. In addition, it requires neither energy nor water to be stored, and remains stable at room temperature.

Biomemory’s technological vision

Founded in 2021Biomemory relies on synthetic biology to develop processes to produce long biosourced, biocompatible and bio-secure DNA fragments. The company converts biomass into digital data, creating a system it calls DNADRIVE. This approach allows stable and completely independent storage of energy resources. Ultimately, Biomemory aims to drastically reduce storage costs: where current DNA synthesis solutions cost around $1 per kilobyte, the company is targeting a cost of $1 per terabyte after optimization.

After fundraising 5 million euros in seed, led by eureKARE and the French Tech Seed Fund (managed by Bpifrance). Biomemory lifts 17 million euros during a round table led by Crédit Mutuel Innovation in order to further develop the technology, industrialize the processes, and launch a pilot phase by 2030.